ORBIMED ADVISORS LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase |
2024-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ORBIMED ADVISORS LLC | 718,200 5.900% |
129,000 (+21.89%) |
Filing |
| 2024-11-14 6:41 pm Purchase |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
ORBIMED ADVISORS LLC | 589,200 4.900% |
589,200 (New Position) |
Filing |